APA (7th ed.) Citation

TA, N., NK, M., M, M., J, A., AR, B., Y, J., . . . J, D. (2025). Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy. Neurology, 104(6), e213393. https://doi.org/10.1212/WNL.0000000000213393

Chicago Style (17th ed.) Citation

TA, Nelson, et al. "Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy." Neurology 104, no. 6 (2025): e213393. https://doi.org/10.1212/WNL.0000000000213393.

MLA (9th ed.) Citation

TA, Nelson, et al. "Clinical Reasoning: Assessing New Neurologic Deficits in Patients With Hematologic Malignancy on Bruton Tyrosine Kinase Inhibitor Therapy." Neurology, vol. 104, no. 6, 2025, p. e213393, https://doi.org/10.1212/WNL.0000000000213393.